Abstract
We report the use of topical cidofovir to treat patients with human monkeypox. We found that lesions on the trunk and limbs responded better than facial lesions, while anogenital lesions were affected by local irritation, leading to eventual discontinuation of treatment.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have